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Summary: A definitive method is described for the measurement of oestradiol-17ß in human serum. The
method is based on the principle of isotope dilution-mass spectrometry. The analytical procedure consists of
the following Steps:
(1) addition of [4-14C]oestradiol-17ß to the plasma sample;
(2) extraction of the 14C-labelled and the non-labelled oestradiol-17ß with dichloromethane;
(3) purification of the oestradiol-17ß fraction by column chromatography on Sephadex LH-20;
(4) formation of the 3,17ß-diheptafluorobutyric ester of oestradiol-17ß;
(5) selected ion monitoring at m/z-values 664 and 666 by gas liquid chromatography-mass spectrometry.
The accuracy of the method is based on the high specificity of mass spectrometry and on the exact control of
recovery employing the principle of isotope dilution. Coefficients of Variation from day to day varied between
1.0% and 2.5% in the ränge of 0.319 to 3.53 nmol/1. The lower limit of detection (ratio of signal to noise 3:1)
is 5 pg oestradiol-17ß per sample.
Bestimmung von östradiol-17ß im menschlichen Serum mit Hilfe der massenspektrometrischen Isotopen-
Verdünnungsanalyse
Definitive Methoden in der Klinischen Chemie, II
Zusammenfassung: Es wird eine definitive Methode zur Bestimmung von östradiol-17ß im menschlichen
Serum beschrieben, die auf dem Prinzip der massenspektrometrischen Isotopenverdünnungsanalyse beruht.
Das analytische Verfahren umfaßt folgende Schritte:
(1) Zugabe von [4-14C]Östradiol-17ß zu der Serumprobe;
(2) Extraktion des 14C-markierteri und des nachzuweisenden nichtmarkierten Östradiol-17ß mit Dichlor-
methan;
(3) Reinigung der ÖstradioM7ß-Fraktion durch Säulenchromatographie an Sephadex LH-20;
(4) Bildung des 3,17ß-Diheptafluorbuttersäureesters von östradiol-17ß;
(5) massenspektrometrische Registrierung ausgewählter Ionen bei den m/z-Werten 664 und 666 während
der Gaschromatographie.
Die Richtigkeit der Methode beruht auf der hohen Spezifität des massenspektrometrischen Nachweises und
auf der genauen Kontrolle der Wiederfindung unter Anwendung des Isotopenverdünnungsprinzips. Die
Variationskoeffizienten von Tag zu Tag lagen zwischen 1,0% und 2,5% im Bereich von 0,319 und 5,53 nmol
östradiol-17ß/l. Die untere Nachweisgrenze (bei einem Signal-zu-Rausch- Verhältnis von 3:1) ist 5 pg östra-
diol-17ß pro Probe.
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Introduction
At present, methods for the determination of steroid
hormones in human serum are based almost entirely
on the principle of enzyme or radioimmunoassay.
These methods are widely used and have proved to
be of great value in the diagnosis öf endocrine dis-
orders, even though the results obtained by different
methods and laboratories seem to vary greatly, äs re-
cently shown by a report on the results of quality
control surveys for the determination of steroid hor-
mones (1). It therefore appeared necessary to devel-
op reference and definitive methods for the determi-
nation of steroid hormones, according to the recom-
mendations on quality control of the International
Federation of Clinical Chemistry (2, 3), in order to
provide a basis for the improvement of the accuracy
of routine methods.
In a previous article in this series (4) a definitive
method for the measurement of cortisol in human
blood was reported. In the present paper a definitive
method for the determination of oestradiol-17ß in-
volving isotope dilution-mass spectrometry is pro-
posed.
Principle of the Method
Oestradioi-17ß in a serum sample is equilibrated
with a definite amount of isotopically labelled oes-
tradioi-17ß. The steroids are extracted by using an
organic solvent and then subjected to column chro-
matography for further purification. For gas chroma-
tography-mass spectrometry, the phenolic steroids
are converted to heptafluorobutyric ester deriva-
tives. This is followed by combined gas chromatogra-
phy-mass spectrometry: During gas chromatography
the molecular ions of the non-labelled äs well äs of
the isotopically labelled oestradioi-17ß derivative
are recorded continously by the mass spectrometer.
The concentration of oestradiol-17ß in the serum
sample is calculated from the isotope ratio äs mea-
sured by mass spectrometry and from the known
amount of isotopically labelled oestradioi-17ß added
to the serum sample.
Materials and Procedure
Reagents
[4-14C]Oestradiol-17ß (spec. radioactivity 1.924 GBq/mmol,
84% 14C) was obtained from the Radiochemical Centre, Amer-
sham, UK; the radiochemical purity of the material was checked
by thin layer chromatography on plates of silanised silica gel
(Merck, Darmstadt, FR Germany); the radioactivity was moni-
tored by using the LB 282 TLC Linear Analyzer (Berthold, Wild-
bad, FR Germany). Oestradioi-17ß was a reference preparation
obtained from the Tenovus Institute for Cancer Research, Car-
diff; the same material, crystallised from aqueous ethanol, was
used äs preliminary reference material (017/3/6/137/78/
BCRUK) for a project of the Community Bureau of Reference of
the Commission of the European Communities. Heptafluorobu-
tyric anhydride was purchased from MercJk^ (Darmstadt, FR Ger-
many).
Oestriol-3,16a,17ß-pentafluoropropipnic ester, used äs reference
substance for calibrating the mass spectrometer, was prepared by
reacting oestriol (Schering, Berlin-West) with a mixture (1: l by
vol) of pentafluoropropionic anhydride (Pierce, Rotterdam, The
Netherlands) and dry acetonitrile (Merck, Darmstadt, FR Ger-
many) for 30 min at 60 °C. Dichloromethane, used for the extrac-
tion of oestradioi-17ß from the serum samples, was distilled prior
to use. Sephadex LH-20 for column chromatography was ob-
tained from Pharmacia (Freiburg, FR Germany) and a-naphthol
was supplied by Merck (Darmstadt, FR Germany). All reagents
and solvents were of analytical grade.
Glassware
Volumetrie flasks used for the preparation of the oestradioi-17ß
Standard Solutions (concentrated stock solution and diluted solu-
tion for final use) were offöcially calibrated. For the dilution of the
oestradioi-17ß Standard stock solution äs well äs for the sampling
of serum, enzyme lest pipettes (l ml, 2 ml and 5 ml total volume,
Blaubrand-Ionodur, Brand, Wertheim, FR Germany) were cali-
brated prior to use by pipetting and weighing appropriate
amounts of water at 20 °C.
For pipetting the final diluted oestradioi-17ß Standard solution
and the [4-I4C]oestradiol-17ß Standard solution a 100 and a
25 syringe (SGEj Melbourne, Australia) equipped with repeat-
ing adaptors were used respectively. The 100 syringe was cali-
brated by sampling and weighing 50 of watet. By using syringes
with direct displacement of the volume the differences of surface
tension between water and ethanol do not have any effect on the
calibration. The loss of water, due to evaporation of the solvent,
during the sampling and weighing procedure, was corrected by
weighing the water samples 45 s and 90 s after sampling and cal-
culating the original weight of 0 s.
Weighing Procedure
The reference material and the 50 water samples for calibrating
the 100 syringe were weighed with an electronic balance (mod-
el 4135, Sartorius, Göttingen, FR Germany). The accuracy of the
balance was checked with officially calibrated weights.
Instruments and Settings
An LKB 9000 combined gas chromatograph/mass spectrometer
equipped with the LKB 2031 Computer System (Boehririger,
Mannheim, FR Germany) or a Finnigan 1020 System (Finnigan
, Bremen, FR Germany) were used alternately. With the
LKB Instrument, the ion source äs well äs the molecular Separator
were operated at 290 °C. The energy of the electron beam was
26 eV and the ionising current 120 . The high voltage at the
electron multiplier was 3400 V. The multiplier of the Finnigan
Instrument was set to 2200 V. Both Instruments were operated at
a resolution of about 500 (10% valley definitiqn). For gas liquid
chromatography a fused silica capillary column (0.32 mm 25 m)
was used containing a film of 0.1 SE-30 or SE-52 which is
chemically bonded to the surface (Macherey-Nagel, Düren, FR
Germany). The column was operated at 260 °C using helium äs a
carrier gas (inlet pressure 40 kPa). Samples were introduced into
the column by a moving-needle-solid-irilet System (5) obtained
from Chrompack (Berlin-West).
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Sample preparation
Twenty five microlitres of an ethanolic solution, containing ap-
proximately 280 pg of [4-14C]oestradiol-17 , were added to
0.5-5 ml serum, using the 25 μΐ syringe equipped with the repeat-
ing adaptor. In order to obtain l: l isotope ratios, which are most
favourable in definitive measurements, the amount of serum to be
used in the experiment was first determined by a preliminary anal-
ysis. The serum sample was equilibrated with the labelled oestra-
diol-17 by gently shaking the test tube for 30min at room
temperature. Dichloromethane (15 ml), containing 2 μg a-naph-
thol s a carrier substance, was added and the mixture mechani-
cally shaken for 30 min at room temperature.
The aqueous phase was then drawn off, and the organic phase
washed twice with l ml water and evaporated to dryness under
nitrogen at 60 °C.
Column Chromatography
The column was prepared by filling a glass column (30 x 0.4 cm),
equipped with a fritted disc, with l g of Sephadex LH-20. The
column was rinsed with 100 ml of methanol and then equilibrated
with 15 ml of a solvent mixture composed of dichloromethane/
cyclohexane/methanol/water (100 + 80 + 15 + l, by vol.). The
residue of the purified plasma extract was taken up twice with
100 μΐ of the solvent and transferred to the column. The column
was first washed with 9 ml of the solvent mixture and the oestradi-
ol-17 fraction eluted with an additional 2 ml of solvent. The elu-
tion pattern is dependent on temperature, and there may be slight
variations between batches of Sephadex LH-20. It is therefore
advisable to check the exact position of the oestradiol-17 frac-
tion by chromatographing a small sample of [4-14C]oestradiol-17
on a separate column and measuring the radioactivity in 0.5 ml
fractions in a liquid scintillation counter (Nuclear Chicago Mark
II, Zinsser, Frankfurt, FR Germany). A typical elution profile is
shown in figure 1. The oestradiol^n fraction obtained after co-
lumn chromatography was collected in conical test tubes (total
volume 2 ml) and the organic phase evaporated under nitrogen at
60 °C.
When the columns have been washed after each Chromatographie
run, they may be reused s many s ten times, before it is neces-
sary to repack them.
20000 -
-E 15 000,-
§10000
"'S 5000-
6 θ 10 12
Eluiion volume [ml]
Fig. 1. Elution profile after chromatography of 1.85 KBq
[4-14C]oestradiol-17 on a column (30 x 0.4 cm) of
Sephadex LH-20 (l g).
Formation of Derivatives
The oestradiol-17 containing residue in the conical tube was
reacted with a mixture of heptafluorobutyric anhydride and ace-
tonitrile (l + 4, by vol.) for 30 min at 60 °C. The reagent mixture
was evaporated under nitrogen at 60 °C.
Preparation of Standard Solutions
For the measurement of Standard samples, calibrated Solutions of
14C-labelled and non-labelled oestradiol-17 were prepared. For
the 14C-labelled oestradiol-17 Standard solution the radioactive-
ly labelled oestradiol-17 (370 KBq) which is purchased in 0.5 ml
benzene/ethanol was transferred to a test tube (2 x 8cm); the
solvent was evaporated and the [4-14C]oestradiol-l 7 dissolved in
10ml ethanol, thus yielding a concentrated stock solution. Fifty
microlitres of this solution were diluted with 25 ml ethanol, which
produces a solution of approximately 280 pg/25 μΐ. The Solutions
were stored at —20 °C and allowed to equilibrate to 20 °C prior to
use.
For the preparation of the non-labelled oestradiol-17 Standard
solution, an exact amount of 2.284mg oestradiol-17 was
weighed into a 500 ml Volumetrie flask (officially calibrated, esti-
mated inaccuracy 0.25 ml). The flask was filled up to the calibra-
tion mark with methanol at 20 °C and the contents shaken vigor-
ously in order to bring about complete dissolution and distribu-
tion. This solution was used s concentrated stock solution and
stored at -20 °C
For the preparation of a diluted oestradiol-17 solution, 0.5 ml of
the concentrated stock solution was transferred to a 500 ml volu-
metric flask (officially calibrated, estimated inaccuracy less than
0.25 ml) using an enzyme test pipette (calibrated by pipetting and
weighing 12 samples of 0.5ml water at 20 °C, volume =
0.50147 ml ± 0.0016 ml (SD)). The 500 ml Volumetrie flask was
filled with methanol at 20 °C to the calibration mark and the con-
tents shaken vigorously for distribution. The final diluted oestra-
diol-17 Standard solution contained 0.22907 ng/50 μΐ. This solu-
tion was stored at -20 °C prior to use.
Preparation of Standards
Three different Standards were included in each analytical series:
Standard 7, prepared in triplicate, consisted of a mixture of 100 μΐ
of the ethanolic [14C]oestradiol-17 Standard solution (pipetted
with the 25 μΐ syringe equipped with a repeating adaptor) and
150 μΐ of the diluted oestradiol-17 Standard solution. The non-
labelled oestradiol-17 solution was sampled by pipetting 50 μΐ
thrice with the calibrated 100 μΐ syringe which was fixed with the
repeating adaptor at the 50 μΐ mark. The exact volume of the syr-
inge was determined by pipetting and weighing 50 μΐ water twelve
times at 20 °C; the corrected volume was 49.4496 μΐ ± 0.1287 μΐ
(SD). With respect to this calibration, the exact amount of non-la-
belled oestradiol-17 in Standard sample l was calculated to be
0.6796 ng.
Standard 2, prepared in six replicates, consisted of a mixture of
100 μΐ of the ethanolic [4-I4C]oestradiol-17 Standard solution
and 200 μΐ of the diluted oestradiol-17 Standard solution. For
sampling the non-labelled oestradiol-17 solution, 50 μΐ were pi-
petted four times with the calibrated 100 μΐ syringe. The amount
of non-labelled oestradiol-17 in Standard 2 was 0.9062 ng.
Standard 3, prepared in triplicate, was a mixture of 100 μΐ of the
ethanolic [4-14C]oestradiol-17 Standard solution; the non-la-
belled material was pipetted with the calibrated ΙΟΟμΙ syringe
(50 μΐ five times). Standard 3 contained 1.1328 ng oestradiol-17 .
The amount of [4-I4C]oestradiol-17 in the Standard samples was
four times the quantity added to the serum samples. Therefore, in
the calculation of analytical results, the amounts of non-labelled
oestradiol-17 in the three different Standards must be divided by
four.
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The Standard mixtures were evaporated under nitrogen at 60 °C
and the residues were dried under vacuum in a desiccator. The
heptafluorobutyric ester derivatives were prepared äs described
above.
It should be noted that the exact weight of [4-14C]oestradiol-17ß
in Standards and samples is not important. However, it is neces-
sary that the amount of [4-l4C]oestradiol-17ß in the Standards is
exactly the same or an exactly known multiple of that added to the
serum samples. This was achieved by using the same syringe with
the repeating adaptor for spiking the serum and preparing the
Standards. Moreover, the amount of non-labelled oestradiol-17ß
in the Standard samples must be exactly known.
Gas Chromatography-Mass Spectrometry
With the LKB Instrument, 20 g of oestriol-pentafluoropropion-
ate was introduced into the ion source of the mass spectrometer,
using a direct inlet System. The magnetic field was adjusted to the
molecular ion of the oestriol derivative (m/z 726). This fnolecular
ion is used to continuously correct, by means of the Computer, the
temperature-dependent drift of the magnetic field strength during
the actual recordings of the oestradiol-17ß specific m/z-values.
The high voltages necessary for the recording of these m/z-values
(664 and 666) are calculated by the Computer and adjusted by
means of a digital-analogue Converter.
With the Finnigan Instrument the spectrometer was respectively
scanned during gas chromatography over two small mass ranges
(663.750 to 664.250 and 665.750 to 666.250) which include the
m/z-values to be recorded. It was thereby ascertained that the
spectrometer records the peak maxima even if the mass calibra-
tion of the Instrument is drifting during the day.
With both Instruments, the data obtained during gas chromato-
graphy at the oestradiol-17ß specific m/z-values are continuously
recorded by the Computers and stored on magnetic discs. The sig-
nal for each of the m/z-values is integrated over a period of
140 ms with both Instruments. For the final inspection of the peak
shapes, the selected ion monitoring chromatograms are recon-
structed by the Computers and made visible on a display. Quantit-
ative evaluation of peak heights was carried out either manually
with a cross hair Cursor or automatically by the Computer pro-
grammes.
The mixture containing the oestradiol-17ß derivative was injected
into the gas liquid chromatography column, which was connected
to one of the two mass spectrometry Systems. Since the amount of
substance available for the analysis of oestradiol-17ß is rather low
(pg-range), the complete sample must be injected into the gas
chromatograph-mass spectrometer to obtain an accurate record-
ing. This was accomplished by dissolving the residue of the deriva-
tive formation, which was carried out in small tapered test tubes,
in approximately ten microliters of cyclohexane. The solution was
aspirated into a 10-microliter-syringe and transferred in quanti-
ties of 2-3 microliters to the tip of the glass needle of the solid
injection System (5). The solvent of each portion was evaporated
to dryness within the moving-needle-solid-inlet System. After the
total sample had been concentrated on the tip of the needle, which
takes about 1-2 min, the substance was injected by rapidly mov-
ing the glass needle into the hot space (300 °C) just ahead of the
column.
In order to keep the measurement system under continuous con-
trol it is of utmost importance that the serum and Standard sam-
ples are injected alternately.
A selected ion recording äs printed by the Computer after process-
ing a serum sample is shown in figure 3.
Calculation Procedure
The concentration of oestradiol-17ß in the serum samples was cal-
culated according to a procedure, the principles and details of
which have been outlined in the first paper of this series on the
measurement of Cortisol (4). The BASIC Computer programme
depicted therein is also applicable to the calculation of the con-
centration of oestradiol-17ß.
Accuracy · r
The accuracy of the method reported herein is based
on the application of the highly specific method of
selected ion monitoring combined with the isotope
dilution principle, which provides the most suitable
means for control of recovery.
Precision
The precision of the method was calculated äs Coefc-
ficient of Variation (CV) from a series of measure-
ments of oestradiol-17ß in a serum sample on differ-
ent occasions. Sixteen different serum pools were in-
vestigated and the results have been summarised in
table L
The overall imprecision was in the ränge 1.0 to
2.5%. This random error is assumed to be derived
from several sources of imprecision:
(1) Isotope ratio measurement (0.5-1.0%, C.V.),
(2) Pipetting of serum samples (~ 0.1%, C.V.),
(3) Pipetting of the labelled internal Standard solu-
tion (~ 0.4%, C.V.).
Tab. 1. Parameters of precision of the isotope dilution-mass
spectrometry method for the determination of oestradioK
17ß in human serum..v
 :. . .
Serum
pool
P.A. 77
P. B. 77
Be 2241
Be 2242
P. 7
P. 8
P. 9
P. 10
P. 11
P. 12
P. 13
S. 14
S. 15
S. 16
S. 17
S. 18
Oestradiol-17ß
(nmol/1)
0.319
1.10
0.382
1.85
1.015
1.361
0.964
0.836
1.133
0.794
1.169
2.06
3.53
2.78
1.364
0.731
n
8
8
8
8
6
14
8
8
8
13
16
15
10
9
10
10
Standard
Deviation
(nmol/I)
0.0058
0.0280
0.0059
0.0230
0.0120
0.0297
0.0152
0.0087
0.0190
0.0120
0.0289
0.0476
0.0690
0.0400
0.0230
0,0120
Coeificient of
Variation
1.8
1.9
.5
.3
.2
2.2
.6
.0
1.7
1.5
2.5
2.3
2.0
1.4
1.7
1.6
Sensitivity
The mass spectrometers used in this investigation
were capable of measuring Sjig oestradioHTß with
a signal to noise ratio of 3:1.
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Discussion
The sensitivity and specificity of selected ion moni-
toring are improved by selecting a derivative, the
mass spectrum of which exhibits an ion of high rela-
tive intensity at a high m/z-value. As may be Seen
from the mass spectrum in figure 2, the heptafluoro-
butyric ester of oestradiol-17 proved to be the most
suitable derivative with a molecular ion at m/z 664.
By introducing two heptafluorobutyric groups the
molecular weight of the phenolic steroid is increased
from 272 to 664. At this high m/z-value there is only
little interference, if any, to be expected from ac-
companying biological material and from the contin-
uous bleeding of the gas liquid chromatography co-
lumn, s may be seen from the selected ion recording
in figure 3. The specificity of the method is further
improved by the use of fused silica capillary columns
in gas liquid chromatography.
The high sensitivity of the method using the hepta-
fluorobutyric ester derivative may be explained from
the fairly high abundance of the molecular ion at m/z
664, which forms the base peak of the mass spec-
trum. The lower limit of detection of the mass spec-
trometers used here is approximately 5 pg oestradi-
ol-17 . Therefore, the procedure may be used for
the measurement of oestradiol-17 in biological
rnaterials ranging from 20-30pg with a fairly high
degree of reliability. However, for the definitive
measurement, the use of sufficient serum to provide
at least 200 pg in each individual sample is recom-
mended.
In view of the low concentration of oestradiol-l-7 in
normal human serum, the total amount of the oes-
tradiol-17 derivative originating from one sample
should be subjected to combined gas chromatogra-
phy-mass spectrometry. This is achieved by using the
splitless moving needle solid injection technique (5).
Phenolic steroids in general are sensitive to irreversi-
ble adsorption by glassware during the analytical
procedure; for this reason α-naphthol was added s a
carrier substance to the initial sample s well s to
the eluate of the Sephadex column.
For the development of a definitive method, the
pure analyte s well s a suitable isotopically labelled
compound of the same chemical structure are neces-
sary prerequisites. As primary reference material, an
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Fig. 2. Mass spectrum (Computer print) of the heptafluorobutyric ester of oestradiol-17 . Mass spectrometer: LKB 9000; direct inlet
probe: 45 °C; ion source: 20 eV, 60 μΑ, 250 °C.
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Fig. 3. Selected ion recording (Computer print) of the heptafluorobutyric ester derivative of oestradioMTß (lower trace) and
[4-14C]oestradiol-17ß (upper trace) after processing a serum sample.
oestradiol-17ß preparation was used which was pre-
pared for a project of the Community Bureau of
Reference of the European Communities.
14C-Labelled oestradiol-17ß was selected in the
present study äs internal Standard material in order
to avoid any risk of the label being changed during
the analytical procedure, äs may happen with the tri-
tium or deuterium labelled compounds recom-
mended by several investigators (6-10). The 14C-la-
belled steroid can be replaced in the future by the
non-radioactive 13C-labelled oestradiol-17ß which at
present is not yet commercially available. The ste-
roid should contain a minimum of two or preferably
more 13C-atoms in order to minimise interference
with the naturally occuring isotopes during selected
ion monitoring.
In order to improve the precision of the method, the
final measurement of the definitive values should be
carried out at an isotope ratio of about 1. This ratio
is obtained by adjusting the volume of the plasma
sample rather than the amount of internal Standard
[4-14C]oestradiol-17ß.
The hierarchy cöncept of tfiethods in clinical chemis-
try äs outlined in the "Approved Recommendation
(1978) on Quality Contröl in Clinical Chemistry"
(3), defines a definitive method äs a procedure
which, after exhaustive investigation, is found to
have no kiiown source of inaccuracy or ambiguity. In
practice, there is no final proof of accuräcy even for a
definitive method. It should be mentioned that some
possible sources of error still remain. For example,
the primäry reference oestradiol-17ß may contain up
to 0.5% of impurities.
A further source of error may lie in the inaccuracy of
the test weights for calibrating the balances, which is
probably less than 0.5%. Finally a random error of
1.0 to 2.5%, arising from the imprecision of the iso-
tope ratio measürement and the pipetting of serum
and Standards is associated with each individual ana-
lytical result. Nevertheless, it may be stated that düe
to the high specificity of the selected ion monitoring
technique and the accurate control of recovefy by
.°the isotope dilution principle, the results obtained by
the present method represent jthe nearest approxi-
mation to the true value.
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Following the preliminary report of this technique
(l 1) the method has now been in use in the laborato-
ry for more than five years. Oestradiol-17ß has been
determined regularly in serum and plasma pools
used for quality control surveys of the Deutsche Ge-
sellschaft für Klinische Chemie. The definitive
values for oestradiol-17ß äs well äs for five further
steroid hormones, have provided the basis for the
evaluation of the results of the participants in the
collaborative surveys for hormones (1). This is in ac-
cordance with a concept that has recently been pro-
posed for the evaluation of collaborative surveys in
clinical chemistry by using definitive or reference
method values (12).
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